{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:31Z","timestamp":1792166251394,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1153-y","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T15:02:50Z","timestamp":1563807770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data"],"prefix":"10.1186","volume":"14","author":[{"given":"K. F.","family":"Trefz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Muntau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Kohlscheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Altevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"issue":"2","key":"1153_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","volume":"16","author":"J Vockley","year":"2014","unstructured":"Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16(2):188\u2013200.","journal-title":"Genet Med"},{"key":"1153_CR2","unstructured":"Phenylalanine hydroxylase gene locus-specific database [Internet]. Accessed June 12, 2018. Available from: http:\/\/www.biopku.org\/home\/pah.asp ."},{"issue":"4","key":"1153_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ymgme.2013.09.001","volume":"110","author":"M Cleary","year":"2013","unstructured":"Cleary M, Trefz F, Muntau AC, Feillet F, van Spronsen FJ, Burlina A, et al. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes. Mol Genet Metab. 2013;110(4):418\u201323.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1153_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162.","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"1153_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s004310051008","volume":"158","author":"P Burgard","year":"1999","unstructured":"Burgard P, Bremer HJ, Buhrdel P, Clemens PC, Monch E, Przyrembel H, et al. Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr. 1999;158(1):46\u201354.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1153_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","volume":"30","author":"BK Burton","year":"2007","unstructured":"Burton BK, Grange DK, Milanowski A, Vockley G, Feillet F, Crombez EA, et al. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. J Inherit Metab Dis. 2007;30(5):700\u20137.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1153_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","volume":"154","author":"FK Trefz","year":"2009","unstructured":"Trefz FK, Burton BK, Longo N, Casanova MM, Gruskin DJ, Dorenbaum A, et al. Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study. J Pediatr. 2009;154(5):700\u20137.","journal-title":"J Pediatr"},{"issue":"Suppl 2","key":"1153_CR8","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1007\/s10545-008-0978-7","volume":"31","author":"M Bik-Multanowski","year":"2008","unstructured":"Bik-Multanowski M, Didycz B, Mozrzymas R, Nowacka M, Kaluzny L, Cichy W, et al. Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis. 2008;31(Suppl 2):S415\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1153_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","volume":"124","author":"J Thomas","year":"2018","unstructured":"Thomas J, Levy H, Amato S, Vockley J, Zori R, Dimmock D, et al. Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM). Mol Genet Metab. 2018;124(1):27\u201338.","journal-title":"Mol Genet Metab"},{"issue":"9326","key":"1153_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(02)09334-0","volume":"360","author":"JH Walter","year":"2002","unstructured":"Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, et al. How practical are recommendations for dietary control in phenylketonuria? Lancet. 2002;360(9326):55\u20137.","journal-title":"Lancet"},{"issue":"4","key":"1153_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ymgme.2015.06.010","volume":"115","author":"V Crujeiras","year":"2015","unstructured":"Crujeiras V, Aldamiz-Echevarria L, Dalmau J, Vitoria I, Andrade F, Roca I, et al. Vitamin and mineral status in patients with hyperphenylalaninemia. Mol Genet Metab. 2015;115(4):145\u201350.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1153_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000363391","volume":"65","author":"S Evans","year":"2014","unstructured":"Evans S, Daly A, MacDonald J, Preece MA, Santra S, Vijay S, et al. The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge. Ann Nutr Metab. 2014;65(1):42\u20138.","journal-title":"Ann Nutr Metab"},{"issue":"9491","key":"1153_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059\u201362.","journal-title":"Lancet"},{"issue":"2","key":"1153_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s001120050032","volume":"148","author":"AC Muntau","year":"2000","unstructured":"Muntau AC, Beblo S, Koletzko B. Phenylketonurie und hyperphenylalanin\u00e4mie. Monatsschr Kinderheilkd. 2000;148(2):179\u201393.","journal-title":"Monatsschr Kinderheilkd"},{"key":"1153_CR15","volume-title":"Neugeborenen-Screening auf angeborene Stoffwechselst\u00f6rungen und Endokrinopathien AWMF online - Das Portal der wissenschaftlichen Medizin","author":"U Nennstiel-Ratzel","year":"2011","unstructured":"Nennstiel-Ratzel U, Genzel-Borovicz\u00e9ny O, B\u00f6hles HFC, Gr\u00fcters-Kieslich A, Mohnike KRR, Ensenauer R, et al. Neugeborenen-Screening auf angeborene Stoffwechselst\u00f6rungen und Endokrinopathien AWMF online - Das Portal der wissenschaftlichen Medizin; 2011."},{"issue":"51","key":"1153_CR16","doi-asserted-by":"publisher","first-page":"e9322","DOI":"10.1097\/MD.0000000000009322","volume":"96","author":"A Hermida-Ameijeiras","year":"2017","unstructured":"Hermida-Ameijeiras A, Crujeiras V, Roca I, Calvo C, Leis R, Couce ML. Arterial stiffness assessment in patients with phenylketonuria. Medicine. 2017;96(51):e9322.","journal-title":"Medicine"},{"issue":"8","key":"1153_CR17","doi-asserted-by":"publisher","first-page":"e0135930","DOI":"10.1371\/journal.pone.0135930","volume":"10","author":"P Htun","year":"2015","unstructured":"Htun P, Nee J, Ploeckinger U, Eder K, Geisler T, Gawaz M, et al. Fish-free diet in patients with phenylketonuria is not associated with early atherosclerotic changes and enhanced platelet activation. PLoS One. 2015;10(8):e0135930.","journal-title":"PLoS One"},{"issue":"1","key":"1153_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13023-016-0508-x","volume":"11","author":"ML Couce","year":"2016","unstructured":"Couce ML, Vitoria I, Ald\u00e1miz-Echevarr\u00eda L, Fern\u00e1ndez-Marmiesse A, Roca I, Llarena M, et al. Lipid profile status and other related factors in patients with hyperphenylalaninaemia. Orphanet J Rare Dis. 2016;11(1):123.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1153_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/PAT.0000000000000210","volume":"47","author":"RA Williams","year":"2015","unstructured":"Williams RA, Hooper AJ, Bell DA, Mamotte CD, Burnett JR. Plasma cholesterol in adults with phenylketonuria. Pathology. 2015;47(2):134\u20137.","journal-title":"Pathology"},{"issue":"5","key":"1153_CR20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1017\/S104795111500150X","volume":"26","author":"M Gunduz","year":"2016","unstructured":"Gunduz M, Cakar S, Kuyum P, Makay B, Arslan N. Comparison of atherogenic risk factors among poorly controlled and well-controlled adolescent phenylketonuria patients. Cardiol Young. 2016;26(5):901\u20138.","journal-title":"Cardiol Young"},{"issue":"Suppl","key":"1153_CR21","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.ymgme.2013.08.012","volume":"110","author":"JC Rocha","year":"2013","unstructured":"Rocha JC, MacDonald A, Trefz F. Is overweight an issue in phenylketonuria? Mol Genet Metab. 2013;110(Suppl):S18\u201324.","journal-title":"Mol Genet Metab"},{"issue":"Suppl 1","key":"1153_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jhn.12054","volume":"26","author":"LV Robertson","year":"2013","unstructured":"Robertson LV, McStravick N, Ripley S, Weetch E, Donald S, Adam S, et al. Body mass index in adult patients with diet-treated phenylketonuria. J Hum Nutr Diet. 2013;26(Suppl 1):1\u20136.","journal-title":"J Hum Nutr Diet"},{"key":"1153_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ymgmr.2014.11.003","volume":"1","author":"H Gokmen Ozel","year":"2014","unstructured":"Gokmen Ozel H, Ahring K, B\u00e9langer-Quintana A, Dokoupil K, Lammardo AM, Robert M, et al. Overweight and obesity in PKU: the results from 8 centres in Europe and Turkey. Mol Genet Metab Rep. 2014;1:483\u20136.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"1153_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jped.2014.06.006","volume":"91","author":"VC Kanufre","year":"2015","unstructured":"Kanufre VC, Soares RD, Alves MR, Aquiar MJ, Starling AL, Norton RC. Metabolic syndrome in children and adolescents with phenylketonuria. J Pediatr. 2015;91(1):98\u2013103.","journal-title":"J Pediatr"},{"issue":"9920","key":"1153_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)62026-7","volume":"383","author":"P Heslop","year":"2014","unstructured":"Heslop P, Blair PS, Fleming P, Hoghton M, Marriott A, Russ L. The confidential inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based study. Lancet. 2014;383(9920):889\u201395.","journal-title":"Lancet"},{"issue":"1","key":"1153_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1471-6712.2009.00708.x","volume":"24","author":"MA Daamen","year":"2010","unstructured":"Daamen MA, Schols JM, Jaarsma T, Hamers JP. Prevalence of heart failure in nursing homes: a systematic literature review. Scand J Caring Sci. 2010;24(1):202\u20138.","journal-title":"Scand J Caring Sci"},{"key":"1153_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12877-015-0166-1","volume":"15","author":"MA Daamen","year":"2015","unstructured":"Daamen MA, Hamers JP, Gorgels AP, Brunner-La Rocca HP, Tan FE, Dieijen-Visser MP, et al. Heart failure in nursing home residents; a cross-sectional study to determine the prevalence and clinical characteristics. BMC Geriatr. 2015;15:167.","journal-title":"BMC Geriatr"},{"issue":"5","key":"1153_CR28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10545-012-9548-0","volume":"36","author":"JB Hennermann","year":"2013","unstructured":"Hennermann JB, Roloff S, Gellermann J, Vollmer I, Windt E, Vetter B, et al. Chronic kidney disease in adolescent and adult patients with phenylketonuria. J Inherit Metab Dis. 2013;36(5):747\u201356.","journal-title":"J Inherit Metab Dis"},{"key":"1153_CR29","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757\u201372.","journal-title":"Clin Interv Aging"},{"issue":"3","key":"1153_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10545-011-9417-2","volume":"35","author":"JC Rocha","year":"2012","unstructured":"Rocha JC, Martins MJ. Oxidative stress in phenylketonuria: future directions. J Inherit Metab Dis. 2012;35(3):381\u201398.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1153_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10571-011-9693-2","volume":"31","author":"GS Ribas","year":"2011","unstructured":"Ribas GS, Sitta A, Wajner M, Vargas CR. Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol. 2011;31(5):653\u201362.","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"1153_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11011-015-9763-0","volume":"31","author":"T Preissler","year":"2016","unstructured":"Preissler T, Bristot IJ, Costa BM, Fernandes EK, Rieger E, Bortoluzzi VT, et al. Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria. Metab Brain Dis. 2016;31(3):529\u201337.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"1153_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbadis.2005.02.005","volume":"1740","author":"LR Sirtori","year":"2005","unstructured":"Sirtori LR, Dutra-Filho CS, Fitarelli D, Sitta A, Haeser A, Barschak AG, et al. Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta. 2005;1740(1):68\u201373.","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"1153_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mrgentox.2009.07.013","volume":"679","author":"A Sitta","year":"2009","unstructured":"Sitta A, Manfredini V, Biasi L, Tremea R, Schwartz IV, Wajner M, et al. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat Res. 2009;679(1\u20132):13\u20136.","journal-title":"Mutat Res"},{"issue":"3","key":"1153_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ymgme.2018.09.006","volume":"125","author":"BK Burton","year":"2018","unstructured":"Burton BK, Jones KB, Cederbaum S, Rohr F, Waisbren S, Irwin DE, et al. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria. Mol Genet Metab. 2018;125(3):228\u201334.","journal-title":"Mol Genet Metab"},{"issue":"Suppl","key":"1153_CR36","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.ymgme.2011.08.025","volume":"104","author":"F Trefz","year":"2011","unstructured":"Trefz F, Maillot F, Motzfeldt K, Schwarz M. Adult phenylketonuria outcome and management. Mol Genet Metab. 2011;104(Suppl):S26\u201330.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"1153_CR37","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/hec.2942","volume":"23","author":"M Grunow","year":"2014","unstructured":"Grunow M, Nuscheler R. Public and private health insurance in Germany: the ignored risk selection problem. Health Econ. 2014;23(6):670\u201387.","journal-title":"Health Econ"},{"issue":"42","key":"1153_CR38","first-page":"704","volume":"113","author":"C Dornquast","year":"2016","unstructured":"Dornquast C, Kroll LE, Neuhauser HK, Willich SN, Reinhold T, Busch MA. Regional differences in the prevalence of cardiovascular disease. Dtsch Arztebl Int. 2016;113(42):704\u201311.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"1153_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/pds.3895","volume":"25","author":"F Andersohn","year":"2016","unstructured":"Andersohn F, Walker J. Characteristics and external validity of the German health risk institute (HRI) database. Pharmacoepidemiol Drug Saf. 2016;25(1):106\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1153_CR40","volume-title":"Fachinformation Neugeborenenscreening. Vorsorgeuntersuchung zur Erkennung angeborener Stoffwechselkrankheiten und Endokrinopathien bei Neugeborenen","author":"M Lindner","year":"2008","unstructured":"Lindner M, Bettendorf M, Hoffmann GF. Fachinformation Neugeborenenscreening. Vorsorgeuntersuchung zur Erkennung angeborener Stoffwechselkrankheiten und Endokrinopathien bei Neugeborenen. Heidelberg: Universit\u00e4tsklinikum Heidelberg; 2008."},{"issue":"12","key":"1153_CR41","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/pds.1674","volume":"17","author":"PC Austin","year":"2008","unstructured":"Austin PC. Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score. Pharmacoepidemiol Drug Saf. 2008;17(12):1218\u201325.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1153_CR42","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/sim.2580","volume":"26","author":"PC Austin","year":"2007","unstructured":"Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26(4):734\u201353.","journal-title":"Stat Med"},{"issue":"4","key":"1153_CR43","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","volume":"54","author":"ST Normand","year":"2001","unstructured":"Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387\u201398.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1153_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00031305.1986.10475403","volume":"40","author":"BK Flury","year":"1986","unstructured":"Flury BK, Riedwyl H. Standard distance in univariate and multivariate analysis. Am Stat. 1986;40(3):249\u201351.","journal-title":"Am Stat"},{"issue":"6","key":"1153_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676\u201382.","journal-title":"Am J Epidemiol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1153-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1153-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1153-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T07:30:13Z","timestamp":1721547013000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1153-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1153-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"28 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used anonymized German claims data. Therefore, no ethics approval was needed by an independent ethics committee or institutional review board.The utilized database addresses all data protection regulations in Germany. To ensure the protection of individual data and privacy, regions that are smaller than federal states or patient cohorts with less than 100 individuals were not analyzed in a granular way. Furthermore, patient counts below 5 were reported as \u201c<\u20095\u201d.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IA, MJ, AJ, PL, and CS are full-time employees and stockholders of BioMarin Europe Ltd. KK, JA, CJ, and SB are full-time employees of Xcenda, acting as contractors of BioMarin Europe Ltd. for the execution of this study. FT received honoraria for presentations from BioMarin. AM has been a member of scientific advisory boards supported by BioMarin Europe Ltd. and has received honoraria as a speaker for BioMarin Europe Ltd. FR has received speaker and consulting honoraria from BioMarin Europe Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}